41373-97-1

Upstream product

• 41373-94-8 4-(4-chlorophenyl)-1,2-dihydropyridazine-3,6-dione 

Downstream Products

• 902456-33-1 3-chloro-4-(4-chloro)phenyl-6-(morpholin-4-yl)-pyridazine 
• 902456-35-3 4-(4-chloro)phenyl-6-(morpholin-4-yl)-3(2H)-pyridazinone 
• 902456-41-1 3-[4-(4-chloro)phenyl-6-(morpholin-4-yl)-3(2H)-pyridazinon-2-yl]propanenitrile 
• 902456-39-7 2-[4-(4-chloro)phenyl-6-(morpholin-4-yl)-3(2H)-pyridazinon-2-yl]acetic acid 
• 902456-37-5 ethyl 2-[4-(4-chloro)phenyl-6-(morpholin-4-yl)-3(2H)-pyridazinon-2-yl]acetate 
• 902456-43-3 3-[4-(4-chloro)phenyl-6-(morpholin-4-yl)-3(2H)-pyridazinon-2-yl]propanoic acid 

Relevant academic research and scientific papers

Bicyclic heterocycles as cannabinoind-1 receptor modulators

The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formulas I both alone and in combination with one or more additional therapeutic agents. The compounds have the following general formulas: including all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein B, R1, R2, R3 and x are described herein.